ADD CONDITION

items per page

Pepto

Last content change checked dailysee data sync status

Active ingredient
Calcium Carbonate 400 mg
Other brand names
Drug classes
Blood Coagulation Factor, Phosphate Binder
Dosage form
Tablet, Chewable
Route
Oral
Prescription status
OTC (over the counter)
Marketed in the U.S.
Since 2005
Label revision date
October 1, 2025
Active ingredient
Calcium Carbonate 400 mg
Other brand names
Drug classes
Blood Coagulation Factor, Phosphate Binder
Dosage form
Tablet, Chewable
Route
Oral
Prescription status
OTC (over the counter)
CSA schedule
Not a scheduled drug
Marketed in the U.S.
Since 2005
Label revision date
October 1, 2025
Manufacturer
Procter & Gamble Manufactura S de RL de CV
Registration number
M001
NDC root
58933-446

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

Pepto® KIDS is a chewable antacid that comes in a fun bubble gum flavor, designed specifically for children. It contains calcium carbonate, which helps relieve common stomach issues such as heartburn, sour stomach, acid indigestion, and upset stomach associated with these symptoms.

This product is available in a pack of 24 chewable tablets, making it easy for kids to take when they need relief from discomfort.

Uses

If you're experiencing discomfort from heartburn, sour stomach, or acid indigestion, this medication can help relieve those symptoms. It’s also effective for soothing an upset stomach that comes along with these issues.

You can feel confident using this medication, as it has no known teratogenic effects (which means it doesn't cause birth defects) or nonteratogenic effects. This makes it a safe option for managing your digestive discomfort.

Dosage and Administration

To determine the right dose for you or your child, start by checking the dosing chart based on weight, which is the preferred method. If weight isn't available, you can use age as a guide. For children aged 2 to 5 years who weigh between 24 and 47 pounds, the recommended dose is 1 tablet. For those aged 6 to 11 years who weigh between 48 and 95 pounds, the dose is 2 tablets.

You can repeat the dose as needed, but be careful not to exceed the maximum limit: children aged 2 to 5 should not take more than 3 tablets in a 24-hour period, while those aged 6 to 11 should not take more than 6 tablets. Additionally, it's important not to use the maximum dosage for more than two weeks unless a doctor advises you to do so. Always consult with a healthcare professional if you have any questions or concerns about dosing.

What to Avoid

It's important to be aware of certain guidelines when using this medication. While there are no specific contraindications or risks of abuse, misuse, or dependence associated with it, you should stop using the medication and consult your doctor if your symptoms persist for more than two weeks. This ensures that you receive the appropriate care and support for your health needs.

Side Effects

If you are using this medication, it's important to be aware of some key points. You should stop using it and consult a doctor if your symptoms last more than two weeks. Additionally, if your child is currently taking any prescription medications, it's wise to check with a doctor or pharmacist first, as antacids can interact with certain prescription drugs.

While no specific adverse reactions or side effects were mentioned, staying informed and monitoring your health is always a good practice.

Warnings and Precautions

Before using this medication, it's important to consult with your doctor or pharmacist, especially if your child is currently taking any prescription drugs, as antacids can interact with certain medications.

If symptoms persist for more than two weeks, you should stop taking the medication and contact your doctor for further guidance.

Overdose

It appears that there is no specific information available regarding overdosage for this medication. However, it's important to be aware of the general signs of an overdose, which can include symptoms like extreme drowsiness, confusion, or difficulty breathing. If you suspect an overdose, it is crucial to seek immediate medical help.

In case of an emergency, call your local emergency number or go to the nearest hospital. Always keep medications out of reach of children and follow the prescribed dosage to prevent any potential risks. If you have any concerns or questions about your medication, don’t hesitate to reach out to your healthcare provider for guidance.

Pregnancy Use

If you are pregnant or planning to become pregnant, it's important to be cautious with any medications, including Pepto Kids (calcium carbonate). Unfortunately, there is no specific information available about the safety of using this product during pregnancy, which means that potential risks or necessary dosage adjustments are not clearly defined.

Before taking Pepto Kids or any medication, you should consult with your healthcare provider to discuss your individual situation and any concerns you may have. They can help you make informed decisions that prioritize your health and the health of your baby.

Lactation Use

When it comes to breastfeeding, there is currently no specific information available regarding the effects of this medication on nursing mothers or lactation (the process of producing breast milk). This means that if you are breastfeeding or planning to breastfeed, it’s important to consult with your healthcare provider for personalized advice. They can help you weigh the benefits and risks based on your individual situation. Always prioritize open communication with your healthcare team to ensure the best outcomes for you and your baby.

Pediatric Use

Before giving this medication to your child, it's important to consult with a doctor or pharmacist, especially if they are currently taking any prescription drugs, as some medications can interact with antacids. If your child's symptoms persist for more than two weeks, you should also stop using the medication and seek medical advice. Always keep this and all medications out of reach of children to ensure their safety.

When determining the right dose for your child, refer to the dosing chart based on their weight, which is preferred, or age if weight is not available. For children aged 2 to 5 years, the maximum dosage is 1 tablet, and for those aged 6 to 11 years, it is 2 tablets. Remember, children aged 2 to 5 should not take more than 3 tablets in a 24-hour period, and those aged 6 to 11 should not exceed 6 tablets. It's crucial not to use the maximum dosage for more than two weeks unless directed by a doctor.

Geriatric Use

When it comes to using this medication in older adults, there is no specific information available about dosage adjustments, safety concerns, or special precautions. This means that if you or a loved one is an older adult considering this medication, it’s important to consult with a healthcare provider. They can help determine the best approach based on individual health needs and any other medications being taken. Always prioritize open communication with your healthcare team to ensure safe and effective treatment.

Renal Impairment

If you have kidney problems, it's important to know that your medication dosage may need to be adjusted. Specifically, if your creatinine clearance (a measure of how well your kidneys are filtering waste) is reduced, you should be closely monitored by your healthcare provider. Regular renal function tests are essential to ensure your kidneys are working properly and to help guide any necessary changes to your treatment.

For those with significant renal impairment, a reduced dose of medication is recommended to avoid potential complications. Always communicate with your healthcare team about your kidney health to ensure safe and effective treatment.

Hepatic Impairment

If you have liver problems, it's important to know that your dosage of this medication may need to be adjusted. This is because your liver may not process the drug in the same way as someone without liver issues. Additionally, your healthcare provider will likely recommend special monitoring of your liver function tests (which check how well your liver is working) to ensure your safety while taking this medication.

Caution is advised when using this drug if you have hepatic impairment, as your liver's ability to metabolize (break down) the medication could be affected. Always discuss your liver health with your doctor to ensure the best treatment plan for you.

Drug Interactions

It's important to have open conversations with your healthcare provider about any medications or tests you may be taking. Currently, there are no specific drug interactions or laboratory test interactions noted for this medication. However, every individual’s health situation is unique, and your provider can help ensure that your treatment plan is safe and effective for you. Always feel free to ask questions and share all the medications and supplements you are using to avoid any potential issues.

Storage and Handling

To ensure the safety and effectiveness of your product, it’s important to store it properly. Keep the product in a well-closed container and make sure the temperature does not exceed 25°C (77°F). This helps maintain its quality and prevents any degradation.

When handling the product, always do so with care to avoid contamination. Following these guidelines will help ensure that the product remains safe and effective for your use.

Additional Information

You should take this medication orally. There are no additional details available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experiences. If you have any questions or concerns about your treatment, be sure to discuss them with your healthcare provider.

FAQ

What is Pepto® KIDS?

Pepto® KIDS is a chewable antacid containing calcium carbonate, available in a bubble gum flavor.

What symptoms does Pepto® KIDS relieve?

It relieves heartburn, sour stomach, acid indigestion, and upset stomach associated with these symptoms.

How many tablets are in a package of Pepto® KIDS?

Each package contains 24 chewable tablets.

What is the recommended dosage for children aged 2-5 years?

Children aged 2-5 years should take 1 tablet if they weigh between 24-47 lbs.

What is the maximum dosage for children aged 6-11 years?

Children aged 6-11 years can take up to 2 tablets if they weigh between 48-95 lbs, but should not exceed 6 tablets in a 24-hour period.

Are there any contraindications for using Pepto® KIDS?

No specific contraindications are listed for Pepto® KIDS.

What should I do if symptoms last more than two weeks?

You should stop use and ask a doctor if symptoms last more than two weeks.

Can Pepto® KIDS be taken with prescription drugs?

You should ask a doctor or pharmacist before use if the child is currently taking a prescription drug, as antacids may interact with certain medications.

Is Pepto® KIDS safe to use during pregnancy?

The insert does not provide specific information regarding the use of Pepto® KIDS during pregnancy.

What precautions should be taken for patients with renal impairment?

Patients with renal impairment may need dosage adjustments and should be closely monitored.

What should be done if the product is stored improperly?

Pepto® KIDS should not exceed 25°C and should be preserved in well-closed containers.

Packaging Info

Below are the non-prescription pack sizes of Pepto (calcium carbonate). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Pepto.
Details

Drug Information (PDF)

This file contains official product information for Pepto, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the relief of heartburn, sour stomach, acid indigestion, and upset stomach associated with these symptoms.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Healthcare professionals should determine the appropriate dosage based on the patient's weight, which is the preferred method, or alternatively, the patient's age.

For patients weighing under 24 lbs and under 2 years of age, it is advised to consult a physician for the appropriate dosage. For patients aged 2 to 5 years, weighing between 24 and 47 lbs, the recommended dose is 1 tablet. For patients aged 6 to 11 years, weighing between 48 and 95 lbs, the recommended dose is 2 tablets.

Doses may be repeated as necessary; however, it is critical not to exceed a maximum of 3 tablets for patients aged 2 to 5 years or 6 tablets for patients aged 6 to 11 years within a 24-hour period. Additionally, the maximum dosage should not be administered for more than two weeks unless directed and supervised by a healthcare professional.

Contraindications

There are no specific contraindications listed for this product. However, it is advised to discontinue use and consult a healthcare professional if symptoms persist for more than two weeks.

Warnings and Precautions

Healthcare professionals should exercise caution when recommending this product, particularly in pediatric populations. It is essential to inquire whether the child is currently taking any prescription medications, as antacids may interact with certain drugs. This precaution is critical to ensure patient safety and avoid potential adverse effects.

In the event that symptoms persist beyond two weeks, it is advised that the patient discontinue use and consult a healthcare provider. This recommendation is vital for assessing the underlying cause of the symptoms and determining the appropriate course of action.

No specific laboratory tests are indicated for monitoring in conjunction with this product, and there are no emergency medical help instructions provided. However, maintaining open communication with patients regarding their overall health status and any concurrent medications is paramount for safe and effective use.

Side Effects

Patients should be advised to stop use and consult a doctor if symptoms persist for more than two weeks. It is also important for patients to seek guidance from a healthcare professional before use if the child is currently taking a prescription drug, as antacids may interact with certain prescription medications.

No specific adverse reactions or side effects have been detailed in the available data.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Pepto (calcium carbonate). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Pepto.
Details

Pediatric Use

Pediatric patients should be evaluated for potential interactions with prescription medications before using this product; consultation with a doctor or pharmacist is advised. Antacids may interact with certain prescription drugs, necessitating caution.

For dosing, it is recommended to determine the appropriate dose based on the child's weight, although age may be used if weight is not available. The dosing chart is as follows:

  • For children under 2 years of age (weighing less than 24 lbs), consultation with a doctor is required.

  • For children aged 2 to 5 years (weighing 24-47 lbs), the recommended dose is 1 tablet.

  • For children aged 6 to 11 years (weighing 48-95 lbs), the recommended dose is 2 tablets.

Pediatric patients should not exceed 3 tablets in a 24-hour period for ages 2-5, or 6 tablets for ages 6-11. The maximum dosage should not be used for more than two weeks unless directed by a healthcare professional. If symptoms persist for more than two weeks, the use of this product should be discontinued, and a doctor should be consulted.

It is essential to keep this and all medications out of the reach of children.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

The safety of Pepto Kids (calcium carbonate) during pregnancy has not been established, as the prescribing information does not provide specific data regarding its use in pregnant patients. There are no known safety concerns, dosage modifications, or special precautions outlined for this population. Healthcare professionals should exercise caution when considering the use of this medication in women of childbearing potential and weigh the potential benefits against any unknown risks to fetal outcomes. It is advisable to consult with a healthcare provider for individualized recommendations.

Lactation

There is no specific information available regarding the use of this medication in nursing mothers or any considerations related to lactation. Therefore, healthcare professionals should exercise caution when prescribing this medication to lactating mothers, as the effects on breastfed infants are not well characterized.

Renal Impairment

Renal impairment may necessitate dosage adjustments for patients with reduced kidney function. It is essential that patients with reduced creatinine clearance are closely monitored to ensure safety and efficacy. Regular renal function tests should be performed in patients with kidney problems to assess their condition. For patients with significant renal impairment, a reduced dose is recommended to mitigate potential risks associated with inadequate drug clearance.

Hepatic Impairment

Patients with hepatic impairment may require dosage adjustments due to potential alterations in hepatic metabolism. It is essential to exercise caution when administering the drug to this population. Special monitoring of liver function tests is recommended to ensure patient safety and to assess the need for any further dosage modifications. Regular evaluation of liver function will help in managing the treatment effectively and mitigating any risks associated with compromised liver function.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant regarding the potential for overdose with this medication. In cases where an overdose is suspected, immediate medical attention should be sought.

Healthcare providers are advised to monitor patients closely for any signs or symptoms that may indicate an overdose. These may include, but are not limited to, altered mental status, cardiovascular instability, or gastrointestinal disturbances.

Management of an overdose should be guided by the clinical presentation of the patient. Supportive care is paramount, and symptomatic treatment should be initiated as necessary. It is recommended that healthcare professionals consult local poison control centers or toxicology experts for further guidance on the management of overdose cases.

In summary, while specific overdosage data is not available, healthcare professionals should exercise caution and be prepared to act swiftly in the event of an overdose, ensuring that appropriate interventions are implemented based on the patient's condition.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's potential effects in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are available for SPL code 90375-7.

Patient Counseling

Healthcare providers should advise patients to keep this medication and all other drugs out of the reach of children to prevent accidental ingestion.

Patients should be informed to discontinue use and consult a doctor if their symptoms persist for more than two weeks. This is important to ensure that any underlying conditions are properly evaluated and managed.

Additionally, healthcare providers should recommend that patients consult with a doctor or pharmacist before using this medication if the child is currently taking any prescription drugs. It is essential to be aware that antacids may interact with certain prescription medications, and professional guidance can help avoid potential adverse effects.

Storage and Handling

The product is supplied in well-closed containers to ensure integrity and stability. It is essential to store the product at a temperature not exceeding 25°C. Proper storage conditions are critical to maintain the quality and efficacy of the product.

Additional Clinical Information

The medication is administered orally. There are no additional details available regarding laboratory tests, abuse information, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Pepto, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the FDA Structured Product Label (DailyMed) for Pepto, retrieved by a validated AI data-extraction workflow.

All FDA-listed dosage forms and strengths are shown in the Packaging & NDC Codes section above. Regulatory status appears in the Summary Information panel above and was verified in the FDA National Drug Code directory and the NSDE NDC Directory daily file.

Note: an automated daemon monitors NSDE checksums; when the record for this NDC changes, the new file is pulled instantly and this page is refreshed.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update:

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.